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        Herpes simplex virus type 1 (HSV-1) challenges the host immune   system 
through several mechanisms (Frey, et al., 2009). In vitro, U937 cells (human 
macrophage-like precursor cell line) are not susceptible to HSV-1 infection when 
they are not differentiating (López-Guerrero and Alonso, 1997). Differentiation of 
these cells’ resistance can abrogates their resistance to HSV-1 (Tenney and 
Morahan, 1991). In this study, we examined the effect of HSV-1 infection on 
differentiated and polarized U937 cells. U937 cells are differentiated to M0 cells. 
Then, M0 cells are polarized to distinct phenotypes, M1 or M2. M1 are pro-
inflammatory macrophages while M2 are anti-inflammatory cells. We examined 
the effect of polarization and HSV-1 infection on cellular viability, morphology and 
the expression levels of CD14 and CD86. This study showed that differentiation 
and polarization of U937 cells decreased their viability more than the HSV-1 
infection.  M2 macrophages showed a major decrease in cell viability compared 
to M0 and M1, possibly due to IL-4-inducing apoptosis. Differentiation and 
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polarization of U937 cells up-regulates their CD86 expression levels and down-
regulates their CD14 expression levels. Furthermore, M1 showed the greater 
CD14 + / CD86 + cell population. HSV-1 infection induced some morphological 
changes in M0, M1 and M2 cells. M0-infected cells appeared more rounded while 
M1-infected cells lost their defined shape and became irregular.  Interestingly, 
HSV-1 infection induced M2 CD86 expression (p<0.002), but did not induce 
CD86 expression in M1cells. CD206 expression levels remained unchanged in 
infected and uninfected cells.  Differentiation and polarization of U937 cells 
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             Herpes simplex virus type 1 (HSV-1) is a double stranded DNA virus. It 
belongs to the Herpesvirade family and replicates in the nucleus of infected cells 
(Frey, et al., 2009). HSV-1 is a common human pathogen (Melchjorsen, et al., 
2002), which infects approximately up to 80 percent of world population (Frey, et 
al., 2009) and causes many diseases such as orofacial infections and enciphalitis 
(Melchjorsen, et al., 2010). Once an individual becomes infected with HSV-1, he 
becomes a carrier for life.  The primary infection is often asymptomatic (Frey, et 
al., 2009). Initially, HSV-1 enters the mucosal surfaces through epidermal or 
other epithelial cells.  After the virus initiates an infection at a peripheral site, it 
migrates to the sensory neurons, replicates and causes a latent infection in a few 
of these neurons, (Kodukula, et al., 1999). HSV-1 infection induces the immune 
system to produce significant increase in cytokines, specifically, type I interferons 
(IFNs) (Melchjorsen, et al., 2010). 
 
             Both the innate and adaptive immune system contribute to control of HSV-1 
infection   (Zheng, et al., 2012). The innate immune response is modulated by 
recruitment of several immune cells such as natural killer cells (NK), plasmacytoid 
dendritic cells (pDCs), production of type I interferon (IFN-α and IFN-β)(Chew, et al., 
200), and proinflammatory cytokines (Melchjorsen, et al., 2010).  Additionally, the 
adaptive immune system manages the infection through activation of CD4+ and CD8+ T 
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cells, particularly through production of IFN- γ by NK cells and by T helper 1 cells 
(Kodukula, et al., 1999).    
           
           Macrophage recruitment is critical for controlling HSV-1 invasion 
(Melchjorsen, et al., 2002).  Macrophages exhibit an essential role in host 
resistance in response to HSV-1 infection by two mechanisms. Intrinsic 
resistance is provided by IFN-α/ IFN-β which prevents intracellular virus 
replication, and extrinsic resistance of IFN-γ-activated macrophages which 
inactivates virus, suppresses replication and destroys HSV-infected cells (Cheng. 
et.al., 2000).  Moreover, these phagocytes manage the HSV-1 infection not only 
through presenting viral antigens to responding T cells but also by producing 
several inflammatory cytokines and chemokines (Melchjorsen, et al., 2002).  
Particularly, In early stages of HSV-1 infection macrophages express IFN-γ, TNF-
α, iNOS, and IL-12 which work together to inhibit HSV-1 replication (Kodukula, et 
al., 1999).  
 
            Macrophages are noted for their plasticity and capability to alter their 
function in response to different microenvironments. M1 and M2 polarized cells, 
in particular, are two activated macrophage phenotypes (Mantovani, et al., 2004). 
The classical activation pathway induces macrophage maturation to M1 cells. 
Interferon (IFN-γ), tumor necrosis factor (TNF-α) or bacterial lipopolysaccharide 
(LPS) triggers macrophage differentiation to M1 subtype through the classical 
pathway.  In contrast, M2 population can be induced by IL-4 or IL-13 via the 
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alternative activation pathway (Wang, et al., 2010).  M1 macrophages are 
considered pro-inflammatory phagocytes and produce many cytokines such as 
interleukin 12 (IL-12), (Mantovani. et.al., 2004), which induces other cytokines 
production from NK cells and T lymphocytes in response to pathogens invasion 
(Trinchieri, 1995). Nitric oxide and Il-23 are also produced by M1 cells in 
response to HSV-1 to promote host defense against this virus (Mantovani, et al., 
2004). M2 macrophages are anti-inflammatory cells and produce cytokines such 
as IL-10 that contribute to tissue remodeling and angiogenesis (Kigerl, et al., 
2009).     
 
           M1 and M2 macrophages express several receptors that enable them to 
recognize and then respond to external signals  Both M1 and M2 cells express 
different levels of CD14 and CD86 (Bonato, et al., 2001). Macrophage surface 
protein (CD14) helps TLR4 along with MD2 to recognize LPS signals, thus 
stimulating the macrophage activation to a distinct phenotype with a significant 
inflammatory cytokine response (Parham, 2009). CD86, however, is expressed 
on resting monocytes, rapidly upregulated in macrophages activation (Bonato, et 
al., 2001)  and plays a critical role in T-cell response stimulation after pathogen 
invasion Activation of macrophages by different stimuli such as LPS and IFN-γ 
(M1), or IL-4 (M2) to a distinct phenotype affects their expression levels of CD14 
and CD86, especially in response to HSV-1 infection.   
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Hypothesis: HSV-1-infected U937 cells differentiated to M0 and polarized 
to M1 or M2 phenotypes exhibit distinct changes in cell surface proteins, 








Aims of the current Study: 
 
• Examine the effect of HSV-1 infection on differentiated and polarized 
U937 cells viability and morphology. 
 
• Examine the effect of HSV-1 infection on expression levels of CD14 and 
CD86 in M0, M1 and M2 macrophages. 















          U937 is a human macrophage-like precursor cell line (Tenney and 
Morahan, 1991). It was established from a 37 year-old male patient with 
histiocytic lymphoma ( ATCC).This cell line is used frequently because it exhibits 
many monocytic characteristics, including monocyte-like antigens, functions and 
receptors (Tenney and Morahan, 1991). It has been universally used as an in 
vitro model of macrophages to investigate and examine the effect of several 
human pathogens such as poliovirus, paravirus, HIV and HSV at the cellular level 
(López-Guerrero and Alonso, 1997). For example, In 1992, a study showed that 
an HSV-1 infection of U937cells resulted in a significant increase in HIV 
replication (Feng, et al.,) Additionally, another study conducted in 2000, showed 
that an RSV infection of U937 cells caused a depression in their production of 
TNF-α, inflammatory cytokine, while it enhanced their production of IL-10, an 
anti-inflammatory cytokine (Barr, et al.). Interestingly, in previous studies, 
undifferentiated U937 cells showed a strong resistance to HSV-1 infection. U937 
are not susceptible to (HSV-1) infection when they not treated with any 
differentiating stimuli (López-Guerrero and Alonso, 1997).  
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         Moreover, such resistance was abrogated by treating the U937 cells with 
several inducers to influence their differentiation and alter their resistance to the 
virus (López-Guerrero and Alonso, 1997). Treatment of these cells with phorbol 
12-myristate 13-acetate (PMA) induced their differentiation and thus raised their 
permissivity to HSV-1 infection (Tenney and Morahan, 1991).  Other treatments 
such as vitamin D3 or mezercin (protein kinase C activator) can cause 
macrophage maturation as well; hence, increase their susceptibility to HSV-1. 
After treatment, U937 cells have shown changes in their permissiveness to HSV-
1 infection; however, the exact mechanisms for this susceptibility is unclear 




           Macrophages are large mononuclear phagocytes (Yu, et al., 1990) 
derived from promonocyte precursors. Bone marrow promonocytes differentiate 
to mature blood monocytes which eventually reside in tissues as macrophages 








Figure1: The system of macrophages as mononuclear phagocytes. 
Bone marrow promonocytes mature to circulating monocytes which eventually forms 





           Macrophages play a significant role in the immune system exhibiting 
activities that depend on the inducing agents (Biswas, et al., 2012). Their 
uniqueness relies on their continuous activation; interestingly, they have 
opposing activities, for example, anti-inflammatory versus pro-inflammatory 
functions.  Also, macrophages exhibit tolerogenic and immunogenic activities in 




             Macrophages express a variety of cell membrane receptors which 
enable them to   recognize and act against foreign antigens. Scavenger 
receptors, for instance, bind to a variety of foreign as well as endogenous 
molecules (Peiser  and	   Gordon, 2001). Macrophages are the most critical 
immune cell acting in response to virus invasion. They release several pro-
inflammatory chemokines and cytokines, besides directing other inflammatory 
cells to the infection site (Lannello, et al., 2011). HSV-1 interacts with 
macrophages in several ways. In humans, the differentiation state of these 
phagocytes influences their permissiveness to the virus, although the exact 
mechanism has not been fully defined (Kemp, et al., 1990). When macrophages 
are activated in response to viral attack, they ingest the pathogen and, as antigen 
presenting cells, present the virus antigens to responding T cells (Lannello, et al., 
2011).  They are also able to kill the viruses nonspecifically.  Sometimes these 
mononuclear phagocytes cannot kill the viruses and, instead, allow them to 
replicate and produce a lethal infection (Roitt, 1999). In contrast to epithelial cells 
which go through necrosis after HSV invasion, macrophages undergo apoptosis. 
Unfortunately, the mechanism of this apoptosis is not yet clear (Lannello, et al., 
2011). Ultimately, human macrophages are able to recognize the initial HSV 
infection and produce inflammatory cytokines, interferons (IFNs), and tumor 








              Macrophages play several anti-viral roles. They have intrinsic resistance 
to control the virus replication via type I IFN. This resistance undergoes many 
changes depending on the differentiation states of the macrophages, which can 
be altered either naturally or by in vitro inducers (Tenney and Morahan, 1991). 
Interestingly, macrophages function alternatively in response to their 
microenvironment (Stout, et al., 2005).  In their protective role, they minimize 
inflammation and trigger tissue repair (Varin and Gordon, 2009).  
           
           Polarizing of macrophages by LPS and IFN-γ, a Th1 cytokine, generate an 
activated subtype, M1,17, characterized by enhancement and suppression of 
several secreted and membranous proteins (Yu. et al., 1990).  This path of 
activation is known as the classical pathway (Gordon and Martinez, 2010). M1 
cells exhibit antimicrobial properties and up-regulate expression of certain anti-
microbial enzymes. Inducible nitric oxide synthase (iNOS) is one of those linked 
enzymes that produce nitric oxide from L-arginine (Wang, et al., 2010).  
Additionally, the classical activated M1 macrophages are distinguished by their 
antigen-presenting capacity and production of increased levels of IL-12 and IL-23 
(Mantovani, et al., 2004).  LPS -stimulation of the M1 macrophages’ Toll like 
receptor 4 (TLR4) causes a downstream signaling pathways through MyD88 and 
TRIF. Each of these adaptor molecules leads to activation of several transcription 
factors.  For example, MyD88 activates IRF5 and NF-κB which is also activated 









Figure 2: Macrophage Polarization 
LPS stimulation of NF-κB, IRF5, AP-1 and IRF3 via MyD88 and TRIF (left) versus  
IL-4 stimulation of STAT6, IRF4 and KLF4 through IL-4R (right). 






           M2 is the other phenotype of polarized macrophages. The Th2 cytokine 
IL-4 in addition to IL-13, mediates the M2 alternative activation pathway (Gordon 
and Martinez, 2010). During selected pathogen and parasitic infections, IL-4 is 
released as a Th2 response to work against such invasion. The production of IL-
4 stimulates differentiation of macrophages to M2 cells (Varin and Gordon, 2009). 
Gratchev, et al., (2001) showed that IL-4 induced alternative macrophages 
overexpress extracellular matrix protein (ECM). This overexpression of ECM 
suggests a critical role of M2 in tissue reconstruction. ECM is deposited during 
acute and chronic inflammation, particularly during the healing period.  High 
levels of non-opsonic receptors such as the mannose receptor, CD206 are 
critical markers for M2 human macrophages (Mantovani, et al., 2004). 
 
           Besides the molecular differences between M1 and M2, the production 
levels of certain cytokines is a critical distinguishing tool for each phenotype 
(Wang, et al., 2010). Whereas high levels of IL-10 and low levels of IL-12 are 
markers for M2, M1 cells produce a low level of Il-10 and a high level of IL-12 
(Mantovani, et al., 2004) (Fig.3). While M1 macrophages are involved in 
tumoricidal, microbicidal, and pro-inflammatory activities, M2 macrophages 
engage in anti-inflammatory, immunoregulatory and tissue-remodelling activities 







Figure 3.  Macrophages polarized phenotypes, M1 cells versus M2 cells. 
M1 mirror Th1 response (left). IFN-γ, a Th1- cytokine, and lipopolysaccharides 
(LPS) polarize Macrophages to M1 cells via classical activation pathway. These 
M1 macrophages secrete a high level of IL-12, IL-23 and TNF and a low level of 
IL-10. In contrast, M2 macrophages mirror Th2 response (right). Th2 cytokines 
IL-4 and IL-13 polarize macrophages to M2 phenotype via the alternative 
pathway. M2 macrophages produce high levels of IL-10 and low levels of IL-12 











             HSV-1 belongs to the α-herpesviridae subfamily (Lannello, et al., 2011). 
As a member of the Herpesviridae family, its unique structure is composed of an 
envelope, tegument protein, an icosahedral capsid  that surrounds the core and  
a linear double- stranded DNA genome resides within the core (Kinpe, et al., 
2007)(Fig.4). The HSV-1 envelope is composed of many oligomeric 
glycoproteins. These glycoproteins exert several functions. Some participate in 
viral invasion of host cells, others are involved in disseminating the virus while 
other glycoprotins are responsible for immune evasion. gB and gC have been 




Figure 4. Structure of Herpes simplex virus type I. HSV-I is composed of envelope, 





The bulky HSV-1 genome requires approximately 18 hours to be replicated in the 
nucleus (Peri, et al., 2008) (Fig.5). HSV-1 is more widespread than HSV-2, and 
mostly transmitted through non-sexual contacts in childhood and adolescence 
(Smith and Robinson, 2002).  There are several infection forms in humans (Peri, 
et al., 2008).  Following initial HSV infection, an individual becomes a carrier of 
the virus for life. The primary infection is usually mild or symptomless (Lannello, 
et al., 2011). Moreover, the virus needs a mucosal surface to generate an 
infection (Kinpe, et al., 2007). Contact of HSV-1 with debraded skin or a mucosal 
membrane (Lannello, et al., 2011) results in its adsorbtion to the host cells 
through its envelop glycoproteins. Specifically, cellular heparan sulphate 
receptors interact with virus glycoproteins gB or gC results. Membrane fusion 
and release of viral particles into the cell occurs subsequently, initiation of 
primary infection (Ellermann-Eriksen , 2005). 
 
 
Figure 5. HSV-1 entrance to the host cell 
and glycoproteins participation. Main virus 
composition elements.1) and 2) during 
virus fusion to the cell membrane after 
binding to it. 3) process of infecting the 






Later, HSV-1 attached to neuron receptors on epithelial cells migrates through 
neuron axons to the body of sensory nerves where it resides and turns into a 
latent virus (Lannello, et al., 2011). It stays in dormant in a very few of the host 
sensory neurons until subsequent activation (Peri, et al., 2008).  
           Stress, physical trauma, immunosupression or exposure to radiation 
reactivate the HSV-1 from its latent phase (Lannello, et al., 2011). The infection 
initiation process along with the primary infected cells type determine whether 
virus will be a lytic or latent (Ellermann-Eriksen, 2005). Usually, when a latent 
virus becomes reactivated, infected people develop painful blisters or cold sores 
on their lips (Lannello, et al., 2011). In many cases, skin lesions appear either at 
the same sites of primary infections or near to them (Peri, et al., 2008). Although 
more common in neonates and immunocompromized people, infection of the 
cornea results in keratits and encephalitis in reactivated infections. HSV infection 
is also considered as the primary cause of sporadic infectious encephalitis in 
healthy people (Lannello, et al., 2011). Pattern recognition receptors (PRRs), 
including toll like receptors (TLRs), mediate the primary recognition of HSV-1.  In 
particular, TLR2 and TLR9 recognize HSV-1 surface structure and its DNA, 
respectively. These PRRs promote the expression of pro-inflammatory cytokines 
and IFNs (Melchjorsen, et al., 2010), which activate the primary phagocytes, 
macrophages and other immune system cells (Ellermann-Eriksen, 2005).  
 
           In murine cell line J774A.1, the cytokines signaling within macrophages 
microenvironments have the major effects on cells viability and surface marker 
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expression than the HSV-1 infection.  As human cell line, U937 cells response to 
differentiation treatments and become more permissive to HSV-1. (López-
Guerrero and Alonso, 1997). Here, we examined the effect of polarization 
treatments and HSV-1 infection on these cells as in vitro model of human 
macrophages.      
   





Materials and Methods 
 
Cell lines and Cells culture: 
The U937 human-like macrophage cell line  originated from a histiocytic 
lymphoma. U937 cells were cultured in 1640 RPMI media (Fisher Scientific) 
(Aderka, et al., 1989). The 1640 RPMI was supplemented with 10% heat 
inactivated fetal bovine calf serum (FCS), 50µl/ml gentamicin, 0.01ml/ml pyruvate, 
2 mm l-glutamine, and 10 mm HEPES. Cells were plated in 25 cm2 vented cap 
culture flasks (Fisher Scientific) and incubated in a 37oC -humidified incubator 
supplied with 5% CO2. U937 cells were sub-cultured using fresh 1640 RPMI 
media two times weekly. 
For culturing the HSV-1 and determining the virus titer (plaque assay), 
Vero cells were used. Vero cells (CCL-81, ATCC) were cultured in DMEM (Fisher 
Scientific) with 10% FSC. 100 cm2 petri dishes were used to grow Vero cells. 
Cells were incubated at 37oC and 5% CO2 (Frey, et al., 2009). Cell culture flasks, 
FCS, and cell strippers were purchased from Fisher Scientific. 
 
Polarization treatments: 
 U937 cells were grown in RPMI on plates to 50% confluency.  For cell 
polarizing, different treatments were added to the culture media. To induce 
differentiation of U937 to M0 macrophages, cells were treated with PMA (200 
ng/ml) and incubated at 37oC for 24 hours. After 24 hours, another dose of PMA 
was added. For M1 induction, cells were treated with recombinant human 
interferon gamma, (IFN-γ) at 20ng/ml ( Peprotech,NJ) ,and lipopolysaccharide, 
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(LPS) at 20ng/ml.  Recombinant human interleukin 4, (IL-4) at 100ng/ml 
(Peprotech,NJ) was added to induce M2 phenotype differentiation. The day 
following treatments, the cells were centrifuged and resuspended in 1 ml of fresh 
media for analysis (Frey, et al., 2009). 
 
Cell Viability: 
       After reaching 50% confluncy in culture plates, U937 cells were differentiated.  
For control cells, IFN-γ and LPS (M1) or IL-4 (M2) was applied without the virus.  
For the other group of cells, administration of HSV-1 (MOI of 0.1) along with 
polarization treatments was done (Frey, et al., 2009). After 24 hours, cells were 
transferred to centrifuge tubes and centrifuged for 5 minutes. The supernatants 
were discarded and pellets were resuspended in 1 ml of fresh media. Trypan 
blue dye (Fisher Scientific) was used to perfourm the trypan blue exclusion test 
and viable cells were counted using hemocytometer.  
 
Immunofluorescent staning 
       U937 cells were cultured in cm2 plates in RPMI enriched media. When cells 
were 50% confluent, different treatments were introduced. Cells were treated 
with PMA for 24 hours. The next day, IFN-γ and LPS were added for (M1) cells, 
while IL-4 was added for (M2) cells. HSV-1 was added along with these 
treatments, while the control cell group was not exposed to the virus. After 24 
hours of treatment with or without the virus, cells were washed three times with 
1% BSA, (0.5 gm of bovine serum albumin was dissolved in 50ml of 1X 
phosphate buffered saline). Then cells were fixed with 4% paraformaldehyde for 
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15 minutes at room temperature. Another washing with 1% BSA followed the 
fixation step. Then, cells were permeabilized with iced acetone and the plates 
were then placed in -20oC freezer for 10 minutes. After that, cells were blocked 
with 3% BSA for an hour at room temperature.  Sample staining was done 
following the blocking procedure. Dilutions of antibodies were made using the 
blocking buffer (3% BSA). 
 
Table1. (Antibody Concantrations for Immunofluorescent staning) 
 
 
After adding antibody dilutions, cells were incubated overnight at 4oC. 24 hours 
later, cells were rinsed gently three times with 1% BSA. Coverslips were added 
carefully to the slides along with a mounting medium (Vector Laboratories). 






Stain/ Antibody Concentration  Company  
Red-Phalloidin X 3 µl/million cells Life Tech.  
FITC Anti-human CD14 5  µl/million cells BioLegand 
BV  Anti-human CD86  5  µl/ million cells bioLegand 
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Flow cytometry analysis: 
          U937 cells were cultured on plates. At 50% confluncy, cells were exposed 
to different treatments. As control, cells were treated with PMA for 24 hours. Next 
day, some cells were polarized with LPS and IFN-γ (M1) or IL-4 (M2). The other 
group of cells were treated as well and infected with HSV-1 at the same time.  
Then cells were incubated at 37oC for 24 hours. Then, cells suspensions were 
centrifuged and pellets were re-suspended in 1 ml fresh RPMI media. Numbers 
of cells were determined for each sample in the hemocytometer using trypan 
blue exclusion method. After that, cells were washed three times with 1% 
BSA/PBS.  Following each washing step, cells were centrifuged for 5 minutes.  
Cells were blocked with 3% BSA for an hour at room temperature to prevent any 
non-specific binding of antibodies. Flourochrome-conjugated primary antibodies 
(BioLegand) were diluted in the blocking buffer (0.1-10 µg/ml). Then, cells were 
incubated with the antibody dilutions for one hour at 4C. After that, cells were 
rinsed three times with 1% BSA. Pellets were then suspended in 500µl - 1ml of a 
solution, which was made of 1.5 ml of FCS and 0.15 sodium azide dissolved  in 
15 ml of 1X PBS, following the Abcam.com recommendation. 
Table.2 (Antibody concentration for Flow Cytometry Analysis) 
 
FITC anti-human CD-14 5µl/million cells BoiLegend 
PYC-F anti-human CD-86 5µl/million cells BioLegend 
CD-206  5µl/million cells BioLegend 
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Virus titer determination: 
          After the cells were treated and infected, cell lysate was prepared to 
determine virus titer. Cells were centrifuged for 5 minutes, and fresh media 
(500µl-1 ml) was added to the pellets. Suspensions were placed at -20oC for 24 
hours. Next day, cells were thawed and frozen again at -20co for another day. 
The process of thawing and freezing was repeated two to three times. 
Suspensions were then centrifuged and supernatants were used to infect 
monolayers of vero cells in six-well plates.  Plaque assay was done using serial 
dilution factors (10-1- 10-6) to determine virus plaque forming unit (PFU).    
    
Statistics: 
Sigma Plot.12 software was used to analyze the data. Data are represented as 









Figure 6.Summary of In vitro Differentiation and Polarization steps. 
U937 cells are treated with PMA differentiated to M0 cells. M0 cells treated with 
IFNγ /LPS to be polarized to M1 cells. M0 macrophages treated with IL-4 to be 









 Differentiation and Polarization of U937 cells Decreases their Viability 
 
         Differentiated and polarized cells exhibited a significant decrease in cell 
viability in comparison to the untreated U937 control cells (Fig.8). Following 
treatment with PMA for 24 hours, M0 cells showed a 59% decrease in cell 
viability compared to control cells(p <0.001).  M1 polarized macrophages showed 
a 54% significant decrease in cell viability after IFN-γ and LPS treatments (p 
<0.001). IL-4 treated M2 macrophages displayed a 75% decrease in their viability 
(p <0.001). Interestingly, the differences in cell viability between M0 and M1 were 
significant (p<0.05); the differences between M1 and M2 were also significant (P 
<0.05).  
 
PMA-Stimulation of U937 Monocytes Enhances their Differentiation and 
Causes their Adherent, M0 Macrophages 
       U937 cells are not adherent cells. When cultured, they do not adhere to the 
plates or flasks surfaces. After treated with PMA for 24 hours, they attached to 








Cytokines microenvironment causes Polarization of M0 macrophages to 
activated phenotypes, M1 and M2 
          M0 cells, when treated with IFN-γ and LPS for 24 hours, activated to M1 
macrophages. M1 cells were flattened, and developed some pseudopodia. 
Following treatment with IL-4 M0 cells polarized to M2 macrophages. M2 
macrophages were rounded as M0 cells (Fig.10).  
PMA-Induced Differentiation of U937 Cells Down-regulates their CD14 
Expression Level and Up-Regulates their CD86 Expression Level 
        26.5% of undifferentiated -U937 cells expressed surface protein CD14. 
When differentiated with PMA (200ng/ml) for 24 hours to M0 cells, their CD 14 
expression level significantly decreased to approximately 2% ( p<0.001). Also, 
the PMA differentiation altered the expression level of CD86 in U937 cells. While 
undifferentiated-U937 cells had a low level of CD86 with a mean value of 0.04%, 
M0 had an increased level of CD86 expression, of 18.5%. The increase in CD86 
expression level between undifferentiated-U937 cells and differentiated M0 cells 
was significant (p<0.001) (table.4).  
   
Polarization of Diffrentiated-U937 Cells (M0 macrophages) to M1 and M2 
Phenotypes Alters their CD86 and CD14 Expression levels 
      (Table.3) polarization of M0 macrophages to M1 phenotype significantly 
increased the CD86 expression level (p<0.015) while decreased their CD14 
expression level (p<0.008). 18.53% of M0 cells expressed CD86 while 23.52% of 
M1 macrophages expressed CD86.  On the other hand, M0 cells had a higher 
level of CD14 expression, 1.08%, than M1 cells at 0.44%. Also, IL-4 polarization 
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of M0 cells to M2 activated phenotype significantly increased their CD86 
expression level (p<0.020) and decreased their CD14 expression level (p<0.015). 
While 18.53% of M0 cells were CD86+, 22.43% of M2 cells were CD86+. For 
CD14 expression, M0 showed 1.08% expression level of CD14, while M2 
macrophages had a lower level of CD14, 0.63%. Interestingly, M1 exhibited the 
highest population of CD14+/CD86+ cells with a percentage of 23.71 in 
comparison to M0 and M2. Additionally, there were not any significant differences 




Herpes Virus Type 1 Infection: 
 
HSV-1 infection of polarized Macrophages insignificantly decreases their 
viability  
          HSV-1 infection did not affect U937 cells viability. Virus-infected U937 cells 
exhibited an increase in viability (Fig.12/13). PMA-treated M0 cells showed a 
non-significant decrease in their viability compared to uninfected-M0 cells 
(p>0.05).  HSV-1 infected-M1 macrophages also had an insignificant decrease 
(p>0.05) of their viability compared to M1 uninfected control cells.  Additionally, 
IL-4 polarized-M2 macrophages showed no significant change in their viability 
when infected with HSV-1 for 24 hours. However, infected- M0 macrophages 
showed a 82% decrease in their viability. This reduction was significant (p-value 
<0.001) compared to U937-infected cells. HSV-1 infected -M1 macrophages 
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showed 75% decrease (p-value<0.001) and IL-4 treated M2 macrophages also 
showed a 88% decrease (p-value <0.001) in their viability compare to virus-
infected U937 cells. Collectively, differentiation and polarization of U937 cells 
decrease their viability, not the HSV-1 infection.  
 
HSV-1 Infected M0, M1and M2 Macrophages Exhibit Morphological 
Changes Compared to Uninfected M0, M1 and M2 Cells.  
        Control uninfected M0 macrophages were rounded. HSV-1 infection altered 
M0 morphology in which they became slightly irregular and the infection also 
caused them to cluster (Fig.23). HSV-1 infection also changed the morphology of 
M1 cells. While uninfected-M1 cells appeared to be elongated with defined shape 
and developed some pseudopodia, infected-M1 macrophages became irregular 
and slightly enlarged, although no significant increase in their diameter was 
determined (Fig.25). Also, HSV-1 Infection of IL-4-treated M2 cells changes their 
morphology. HSV-Infected M2 cells exhibited slightly flattened shape in 
comparison to uninfected M2 (Fig.27). Collectively, HSV-1 infection caused most 
of M0, M1 and M2 cells to cluster and to be attached to each other.  
 
 
 HSV-1 infected Undifferentiated U937 Cells and PMA-differentiated M0 
Cells Exhibit no Significant Alterations of their CD14 and CD86 Expression 
levels Compared to Uninfected cells 
          U937 cells and M0 macrophages express both CD14 and CD86. HSV-1 
infection insignificantly changed the expression levels of CD14 and CD86 in 
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undifferentiated U937 and PMA-treated M0 macrophages (p>0.05). Uninfected-
U937 cells had 26.5% of CD14 expression level while infected cells had a 28.5%. 
Also, uninfected U937 cells had a 0.04 % of CD86 and HSV-1 infected cells 
showed an expression level of 0.05. While uninfected M0 cells had a 1.07 and 
18.5 expression levels of CD14 and CD86 respectively, infected-M0 cells had 
1.22 of CD14 and 23% CD86 (Fig.15/16). 
 
 
HSV-1 Infection Induces CD86 expression level in M2 polarized 
macrophages but not in M1phenotype   
        Uninfected M1 cells had 23.52 % expression level of CD86. When M1 cells 
were infected with HSV-1, their CD86 expression level did not change, while 
expression level of CD86 in M2 macrophages significantly increased (p< 0.001) 
after the HSV-1 infection compared to uninfected M2 cells (Fig.17/18). HSV-1 
infected M2 cells showed a significant increase in their CD86 expression 
compared to infected-M0 (P <0.016) or infected-M1 (p <0.002) cells.  However, 
HSV-1 infection of M1 and M2 cells did not significantly alter their CD14 






            HSV-1 infects human cells, induces the immune system and causes 
production of inflammatory cytokines (Melchjorsen, et al., 2010). Macrophages 
play a crucial role in response to viruses. Their microenvironment influences their 
activation into two phenotypes M1 and M2. Classically activated M1 
macrophages are induced by IFN-γ/ LPS and exhibit an antimicrobial features 
with the ability to trigger Th1 responses.  M2 macrophages are induced by IL-4 or 
IL-13 through the alternative activation pathway and promote Th2 functions 
(Lolmede, et al., 2009). M1 cells were characterized by their high production of 
IL-12 and iNOS in response to pathogens (Mantovani, et al., 2004), while the 
anti-inflammatory M2 cells were characterized by their high production of IL-10 
(Gratchev, et al., 2001).  Variation of cytokine production among M1 and M2 
macrophages distinguishes them from other immune cells (Mantovani. et.al., 
2004). In vitro, the human-like macrophages cell line, U937, is highly resistant to 
the HSV-1 infection. Differentiation of these promonocytes with various 
treatments such as PMA removes the primary block of virus replication, and 
disturbs their resistance thus, increasing their permissiveness to the virus 
(Tenney and Morahan, 1991). In this study we examined the effect of HSV-1 in 
differentiated U937 cells. Interestingly, previous studies showed that 
undifferentiated U937 cells have resistance to HSV-1 (Tenney and Morahan, 
1991). Here, we differentiated the U937 cells to M0 macrophages then, polarized 
them to enhance their maturation to M1 or M2 phenotypes. When we 
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differentiated The U937 cells with PMA (200ng/ml) for 24 hours, the monocytes 
matured to M0 macrophages and then cells became adherent.  Further treatment 
of M0 cells with LPS (20ng/ml) and inflammatory cytokine IFN-γ (20ng/ml) causes 
their maturation to M1 proinflammatory phenotype. In contrast, IL-4 treatment of 
M0 leads to anti-inflammatory M2 cells. After differentiation cell viability 
decreased in comparison to control untreated-U937 cells.  M0 viability 
significantly decreased by 59%, and M1 viability decreased by 54% while more 
reduction was found in M2 cells in which their viability decreased by 75%. U937 
lymphoma cells expressing PPARγ (peroxisome proliferator-activated receptor γ), 
which works as an apoptotic-inducers (Konopleva, et al., 2004). IL-4 is one of 
PPARγ ligands (Huang, et al., 1999). Since we used IL-4 as polarization 
treatment for M2 phenotype, the decrease of their viability could result from the 
interaction between apoptotic receptor PPARγ and its ligand IL-4. So, we induced 
apoptosis on these cells by using IL-4 treatment. Other polarization treatments 
such as IL-33 and IL-10 should be tested to support this explanation. 
Interestingly, although mouse macrophages J774A.1 express the PPARγ (Kao, et 
al., 2009) as U937 cells, IL-4 treatment exhibited greater effect on U937 cells 
than those mouse macrophages.  When we infected the differentiated and 
polarized macrophages (M0, M1 and M2) with HSV-1 (MOI=0.1) we found that 
HSV-1 infection decreased viability of M0, M1, and M2 cells in comparison to 
control uninfected U937 cells.  M0 viability decreased by 82%, M1 decreased by 
74% and M2 cells by 88%. Furthermore, the viability of infected- differentiated 
and polarized macrophages did not significantly decrease when compared to 
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uninfected M0, M1 and M2 cells suggesting that the differentiation and 
polarization process exhibit greater effect on these U937 cells than the HSV-1 
infection. We concluded that polarization, rather than HSV-1 infection caused the 
significant alteration on these macrophages similar to what had been found in 
murine macrophages. Interestingly, we also found that HSV-1 infection caused 
morphological changes to these polarized macrophages (M0, M1, and M2).  After 
infection, M0 cells became irregular compared to their prior-infection rounded 
shape. While uninfected M1 macrophages expressed pseudopodia on their 
surfaces, we found that after HSV-1 infection, M1 cells became irregularly 
shaped with fewer pseudopodia.  In M2 macrophages, HSV-1 infection alters 
their oval shape to rounded cells with no vacuoles. Collectively, Infection with 
HSV-1 caused M0 cells as well as M1 and M2 to cluster together and appeared 
in groups.  M1 and M2 macrophages express different levels of surface proteins 
CD14 and CD86 (Bonato, et al., 2001). Similar to Lolmede, et. al (2009), we 
found that M1 macrophages express relatively higher amount of CD86 in 
comparison to M2 cells. Also, we found that the HSV-1 did not alter the 
expression levels of CD14 and CD86 in M0 and M1 over what has been 
observed in uninfected M0 and M1 cells. Interestingly, CD86 expression level on 
M2 macrophages dramatically increased after HSV-1 infection suggesting that 
HSV-1 induced their surface protein expression and caused their further 
maturation like human macrophages.  M1 macrophages exhibited the larger 
proportion of cells expressing both CDs (CD14 +/CD86+) before and after HSV-1 
infection in comparison to M0 and M2 cells.  Mannose receptor CD206 is a 
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marker for M2 macrophages since they express it more than other immune cells 
(Choi, et al., 2010). Here, we examined CD206 expression level in polarized 
macrophages prior to HSV-1infection and after the infection. There was not a 
significant alteration in CD206 expression between polarized -uninfected cells 
and polarized-HSV-infected cells suggesting that HSV-1 infection neither up-
regulates nor down-regulates macrophages’ CD206 expression. Collectively, 
HSV-1 infection up-regulated CD86 expression in differentiated U937 cells and 
polarized to M2 while it did not alter their CD 206 expression. Moreover, CD206 
expression levels on infected cells were similar to control uninfected cells, with 
M2 macrophages showing the highest expression level of 54%. However, 
previous studies suggested no role of CD206 in pathogen invasion. Ultimately, 
our data suggest that differentiated and polarized U937 cells exhibit 
permissiveness to HSV-1 although future study of the HSV-1 mRNA levels in 
these differentiated and polarized cells will provide critical hints about their 
interaction with the virus. 
            Ultimately our data show the possibility of developing an in vitro model 
resembling human macrophage polarized phenotypes (M1 and M2) from U937, 
promonocytes, lymphoma cells and observing their response to HSV-1 infection. 
Differentiation and polarization of these U937 cells not only allow the herpes 
simplex type 1 virus to change their morphology but also surface markers 
expression levels, especially CD86 expression level on M2 macrophages, 




           In future, studying of the effect of other polarization treatments would 
provide a better understanding of the polarization process and its effect on these 
U937 lymphoma cells. Study of M2 macrophages would be a beneficial 
measurement to determine the accuracy of in vitro macrophages activation.  
Specifically, to examine the possibility of IL-4-induced apoptosis on M2 cells, 
polarization of these cells with IL-33 would be beneficial on clarifying the reason 
for the decrease in M2 cells viability because IL-33 signals through nuclear 
receptor, PPARγ as IL-4 (Fig.7). Other polarization treatments could be also used 
in vitro to stimulate M2 phenotype activation such as immune complex (IgG) and 
IL-10, which have been found in vivo to stimulate activation of macrophages to 
M2 cells through alternative signaling pathways. Use of cytokine IL-10 or immune 
complex (IgG), which signal through specific receptors and do not stimulate 
PPARγ, would be beneficial on polarization of M2 cells and examine their viability 
with or without the HSV-1.  Additionally, in vitro stimulation of cytokines 
production in differentiated and polarized U937 cells (M0, M1 and M2) such as 
IL-12 for M1 or IL-10 for M2 would help in determining to which extent these 











Figure.7.Macrophages polarization via multiple signaling pathways. IL-10 
activation of M2 phenotype through specific receptors IL-10R via JAK/STAT 
signaling pathway. lL-33 activation of M2 phenotype through ST2 receptor and 
PPARγ nuclear receptor.  Alternative activation pathway for M2 cells through 
Immune complex (IgG) via its ITIM receptor and SHIP-1 or ITAM receptor and its 

























Figure 8. The effect of differentiation and polarization treatments in cells 
viability in comparison to control untreated U937 cells. M0 macrophages 
showed a 59.5% decrease (p-value <0.001) in cell viability after PMA treatment.  
M1 cells showed a significant decrease in cells viability (54 %, p-value<0.001) 
following 24-hour treatment with LPS + IFN-γ. M2 macrophages exhibited a 
significant decrease in cell viability (75.0%, p-value <0.001) after 24 hours of IL-4 
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Figure 9. U937 cells and PMA-differentiated M0 cells. U937 non-adherent 
cells stained with Texas-Red Phalloidin. M0 cells differentiated with PMA for 24 
hours stained with Texas-Red Phalloidin. M0 cells were rounded compared to 
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Figure 10. Differentiated M0 cells and Polarized M1 and M2 phenotypes. 
M0 cells differentiated with PMA for 24 hours stained with Texas-Red Phalloidin 
were rounded in shape. M1cells treated with LPS/IFN-γ for 24 hours, stained with 
Texas-Red Phalloidin exhibited flattened defined shape and developed some 
pseudopodia . M2 cells treated with IL-4 for 24 hours, stained with Texas-Red  
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Table 3) Summary of Expression levels of CD14 and CD86 in Differentiated and 
Polarized Macrophages 
 
Figure 11. Expression levels of CD14 and CD86 in differentiated and 
Polarized Macrophages. A) CD14 expression in M0, M1 and M2 cells. B) CD86 
expression in M0, M1 and M2 cells. C) Table4. Summary of Expression levels of 
both CD14 and CD86 showing significant differences between M0 and polarized 






Marker M0 P-Value 






M2 VS M0 
CD14 
 
1.08 0.008 0.44 NS 0.63 0.015 
CD86 
 




















Figure 12.Percentage of viable cells following differentiation, polarization 
and HSV-1 Infection. M0, M1 and M2 cells showed a significant decrease in cell 
viability compare to U937 control cells (p-value<0.001). Following HSV-1 
infection, M0, M1 and M2 cells showed insignificant decrease in cell viability 
compare to uninfected control M0, M1 and M2 cells (p-value>0.05).   
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Figure 13.Percentage of Viable Cells following Polarization Treatments.  
A) Cell viability of differentiated and polarized phenotypes. M2 cells showed 
significant decrease (p< 0.036) compare to M0 &M2. B) Cell viability of infected 
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Figure14. U937 Cells Differentiated, Polarized and HSV-1 Infected. U937 
cells undifferentiated, stained with Texas-Red Phalloidin and infected with HSV-1. 
M0 cells differentiated with PMA for 24 hours, stained with Texas-Red Phalloidin 
and infected with HSV-1 were rounded and clustered. M1 cells treated with 
LPS/IFN-γ for 24 hours, stained with Texas-Red Phalloidin and infected with 
HSV-1 M1 cells were irregular and flattened. M2 cells treated with IL-4 for 24 
hours then stained with Texas-Red Phalloidin and infected with HSV-1. M2 cells 

















	  	  	  	  	  	  	  	  	   	  
	  
	  	  	  	  	   	  
	  
Figure 15. Expression levels of CD14 and CD86 in Undifferentiated (-PMA) 
and Differentiated (+PMA) U937 Cells pre / post HSV-1 Infection.  
Flow cytometric analysis of CD14 and CD86 expression levels in U937 and M0 
cells before (Left) and post HSV-1infection (right). Undifferentiated U937 cells 
showed increased levels of CD14 expression before and after HSV-1 infection 
(p<0.001). 41.07% of Infected-U937 cells expressed CD14 while only 1.39% of 
infected- M0 cells expressed CD14. M0 cells showed increased levels of CD86 
expression. Infected-M0 had a 23.30% CD86 positive cells. Figures above 
represent a single experiment. Negative Isotope control was used to set 
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         Table. 4) Comparison of Significant Differences in Expression of CD14 & 
CD86 between Polarized Infected and Polarized Uninfected Macrophages. 
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26.5    2.12 
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Figure 16.Expression levels of CD14 and CD86 in Undiffrentiated-U937 
Cells and PMA-differentiated M0 cells before and after HSV-1 Infection. A) 
Expression level of CD14 in infected and uninfected M0 cells in comparison to 
U937 cells. B) Expression level of CD86 in U937 cells and M0 cells infected and 
uninfected. Uninfceted-M0 showed a significant increase in CD86 expression 
compare to uninfected-U937. C) Comparison of significant differences in 
expression of CD14 & CD86 between polarized infected and polarized uninfected 







           
Figure 17. Expression Levels of CD14 and CD86 in Polarized Infected and 
Uninfected Macrophages. Figures represent flow cytometric analysis of CD14-CD86 
expression levels  in M0, M1 and M2 from a single experiment. M0 showed an increase 
in CD14 and CD86 expression levels after HSV-1 infection (p<0.05).  Infected M1 cells 
showed a sligh increase in CD14. Infected-M2 macrophages showed the highest level of 
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C)   
 
Table.5) Significant Differences between Polarized Infected and Uninfected cells. 
HSV-1 Marker M0 
CM/ SD 
P-Value 










































































Figure18. Comparison of Average percentage of CD14 +   cells and CD86 + 
cells between Polarized Infected and Polarized uninfected Macrophages. 
A) Expression of CD14 in polarized infected and uninfected macrophages. 
Infected M0, M1 and M2 cells showed insignificant changes in their expression 
compare to uninfected cells. B) Expression of CD86 in polarized infected and 
uninfected cells. Infected-M2 cells had a significant increase in CD86 expression 
compare to infected M0 (p<0.006) Infected M1 (p< 0.002) and uninfected M2 
cells (p< 0.001).  C) Table, Significant differences between polarized infected and 




                 
                                                                               




Figure 19. Expression of CD206 in Polarized Macrophages. Flow cytometric 
analysis of CD206 expression levels in polarized Macrophages (M0, M1 and M2 ) 
before (Left) and post HSV-1infection (right).  M0, M1 and M2 showed 
insignificant differences in their CD206 expressions before and after HSV-1 
infection. Figures above represent a single experiment. Negative Isotope control 
































































Figure20. U937 Cells. A) U937 cells stained with Texas-Red Phalloidin for 
Actin.Cells were un-adherent with irregular shape.  B) U937 cells stained with 
FITC conjugated antihuman-CD14 antibodies. Untreated U937 cells expressed 
CD14. (Scale bar = 50µm). 
 
  
                                
 
Figure 21. HSV-1 Infected U937 Cells.  A) Infected U937 cells stained with 
Texas-Red Phalloidin for Actin.  Cells showed irregular shape. B) Stained with 
FITC conjugated antihuman-CD14 antibodies. HSV-Infected U937 untreated 












    
                      
 
Figure 22. M0 Macrophages.  U937 cells treated with PMA for 24 hours. A) 
Actin stained with Phalloidin Texes-Red . Cells were rounded and adherent.  B) 
M0 cells stained with FITC conjugated antihuman-CD14 antibodies. Cells 
expressed CD14. (Scale bar = 50µm). 
 
                       
 
Figure 23. HSV-1 infected M0 macrophages.  U937 cells treated with PMA and 
infected with HSV-1for 24 hours. A) Actin stained with Texes-Red 
Phalloidin .Infected cells were slightly irregular with rounded shape compared to 
uninfected cells and appeared in clusters.  B) M0 cells stained with FITC 
conjugated antihuman-CD14 antibodies. Infected-M0 cells expressed CD14 as 
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Figure 24. M1macrophages.  U937 cells treated with LPS and IFN-γ for 24 
hours. A) Actin stained with Phalloidin Texes-Red. Cells were elongated with 
defined shape and developed some pseudopodia. B) M1 cells stained with FITC 
conjugated antihuman-CD14 antibodies. M1 cells expressed  CD14. (Scale bar = 
50µm). 
 
                  
Figure 25. HSV-1 infected M1 macrophages.  M0 cells treated with LPS/ IFN-γ 
and infected with HSV-1for 24 hours. A) Actin stained with Phalloidin Texes-Red.   
Infected M1 cells became irregular, clustered and slightly enlarged compared to 
uninfected cells. B) M1 cells stained with FITC conjugated antihuman-CD14 
antibodies. M1 cells expressed CD14 as uninfected M1 cells with no significant 













             
Figure 26. M2 Macrophages.  M0 cells treated with IL-4 for 24 hours. A) Actin 
stained with Phalloidin Texes-Red.  M2 cells were rounded and slightly clustered 
B) M2 cells stained with FITC conjugated antihuman-CD14 antibodies. M2 Cells 
expressed CD14 as M1cells. (Scale bar = 50µm). 
 
 
                
Figure 27.  HSV-1 Infected M2 macrophages.  M0 cells treated with IL-4 and 
infected with HSV-1 for 24 hours. A) Actin stained with Phalloidin Texes-Red.  
M2 infected cells were slightly flattened compared to uninfected M2 cells. B) M2 
cells stained with FITC conjugated antihuman-CD14 antibodies. Infected M2 cells 
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Figure28.  U937 Cells Differentiated and Polarized. U937 cells undifferentiated 
stained with Texas-Red Phalloidin were un-adherent irregular cells.  M0 cells 
differentiated with PMA for 24 hours stained with Texas-Red Phalloidin were 
rounded and adherent.  M1cells treated with LPS/IFN-γ for 24 hours, stained with 
Texas-Red Phalloidin were flattened.  M2 cells treated with IL-4 for 24 hours, 
stained with Texas-Red Phalloidin were rounded and cells appeared in groups 
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